Categories Analysis, Consumer

What awaits Best Buy (BBY) beyond pandemic-driven boom?

The company owes the consistent sales performance to the effective execution of its turnaround strategy titled Review Blue

Shares of Best Buy Co. (NYSE: BBY) climbed to an all-time high this month even as the pandemic-driven shift to remote work and home-based learning continue to drive customer traffic. The e-commerce marketplace has reopened the majority of the stores and is leveraging its digital capabilities to ride the ups and downs of the ongoing crisis.

The stock has mostly stayed on an upward trajectory after recovering from the COVID-driven sell-off a few months ago. It has witnessed volatility in the last few weeks but looks overvalued at the current price of around $118. Long-term investors would still find the stock attractive, though it is not free from risks associated with the virus-related uncertainty.

The positive sales momentum seen during the pandemic days can be attributed mainly to stay-at-home trends like working and learning from home. When the Minnesota-based company reported a three-fold growth in e-commerce sales for its most recent quarter, the market’s response was skeptical amid fears that the growth might be short-lived. Underscoring those concerns, the management withheld its full-year guidance.

Factors to Check

Best Buy’s ability to sustain the current momentum will depend on factors like the new stimulus package, variations in the job market, and how the pandemic situation evolves. While the reopening of stores in recent months is catalyzing sales growth, costs related to fulfillment and logistics could impact margins. Performance might also be affected by the continued pressure on inventory, which would require measures to revitalize the supply chain.

Best Buy (BBY) Q2 2021 Earnings Infograph

From Best Buy’s second-quarter 2021 earnings conference call:

“As we look forward, the environment is still evolving and our operating model and supporting cost structure is evolving as well. The pandemic has accelerated the evolution of retail and compelled us to change our operating model in the best interest of our customers and employees. It has also allowed us to expedite some planned strategic changes, that will set us up to emerge from this time even stronger.”

Turnaround Program

The long-term outlook on the company is bullish, thanks to the unique assortment that includes a wide range of electronics and home appliances. Also, the company has come a long way since the days of losing ground to the online invasion of Amazon (AMZN). Currently, it is cashing in on the revamped online platform and the ongoing drive to convert stores into pickup and delivery spots. The management’s turnaround strategy called Renew Blue has been executed effectively with focus on stabilizing revenue streams, reducing costs, optimizing store space, and broadening digital sales.

Record Comps

Despite the widespread disruption, comparable-store sales grew at a record pace in the second quarter, driving up revenues by 4% to about $10 billion. As a result, adjusted earnings climbed 58% to $1.71 per share. The numbers also topped the Street view. When the company reports its third-quarter results on November 24, market watchers will be looking for a 46% increase in earnings to $1.65 per share. Revenues are seen growing about 11% to $11 billion, benefiting from the strong traffic to the website.


Read management/analysts’ comments on Best Buy’s Q2 20201 earnings transcript


Best Buy’s stock traded lower in the early hours of Tuesday, after closing the previous session higher. It has gained 34% since the beginning of the year and 63% in the past twelve months. Currently, the shares are hovering near the all-time highs seen at the beginning of the month. They have outperformed the S&P index and the broad market this year.

Looking for more insights?

Read the full conference call transcript here. It’s free!

Most Popular

Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO

Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training

INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues

Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came

Riding the AI wave, Nvidia looks set to stay on the high-growth path

After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top